Outlaw Laboratory, LP v. DG in PB, LLC

District Court, S.D. California·Decided February 18, 2022·No. 3:18-cv-00840·Unknown

Opinion

IN RE OUTLAW LABORATORY, LP Case No.: 18-cv-840-GPC-BGS LITIGATION. ORDER VACATING TRIAL DATE AND GRANTING PLAINTIFF’S MOTIONS IN LIMINE \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ This case is currently set for a five-day trial beginning on March 8, 2022. Due to the unavoidable congestion of the Court’s trial calendar, and the precedence to which criminal cases are entitled under the Court’s Constitutional obligations, the Court HEREBY VACATES the trial date previously set for this case. A status hearing is set for July 15, 2022 at 1:30 PM. Pending before the Court are Plaintiffs’1 motions in limine. ECF Nos. 388, 389, 390, 391, 392. The Court will address each in turn. A. Motion in Limine No. 1: Amount of Outlaw Settlement (ECF No. 388) Plaintiffs move to exclude the dollar amount of the settlement paid by Outlaw Laboratory, Michael Wear, and Shawn Lynch (“the Outlaw defendants”) as part of the 2021 Settlement between the Outlaw defendants and Plaintiffs. ECF No. 388. Under Federal Rule of Evidence (“Rule”) 408(a), a settlement agreement is inadmissible as evidence, unless for a narrow purpose such as proving a witness’ bias or prejudice. Fed. R. Evid. 408(a). To that end, evidence that Michael Wear and Shawn Lynch agreed to testify as part of the settlement agreement is admissible because it goes to the issue of potential bias. However, the settlement amount itself is inadmissible. The Court further concludes that presenting the amount of the settlement to the jury has the potential to confuse and mislead the jury. The Court HEREBY GRANTS Motion in Limine No. 1 and excludes the dollar amount of the settlement reached between the Outlaw Defendants and the Stores. 1 Because only the claims of Counterclaimants the Stores (Roma Mikha, Inc., NMRM, Inc., and Skyline Market, Inc.) remain in this action, the Court will refer to them as “Plaintiffs” or “the Stores” for ease of reference. B. Motion in Limine No. 2: Criminal Prosecutions of Others (ECF No. 389) Plaintiffs move to exclude “all evidence and argument regarding any criminal prosecutions of importers or other sellers of ‘sex enhancement pills’ of the type that underlie this litigation, and further to exclude evidence and argument regarding the criminal indictment of one of the owners of Outlaw Laboratory, Michael Wear.” ECF No. 389 at 2. Specifically, Tauler Smith proposes to call a Mr. Nam Hyun Lee as a witness and admit his guilty plea. See ECF No. 384 (Pretrial Order) at 9, 18. Tauler Smith also lists as exhibits Michael Wear’s indictment for conspiracy to distribute marijuana and an order setting Wear’s bail conditions. Id. at 18 (Exs. X and Y). The Court will exclude evidence of Michael Wear’s indictment as inadmissible impeachment evidence under Rule 609. Fed. R. Evid. 609. Tauler Smith does not propose evidence of Wear’s actual conviction, nor is it clear why distributing marijuana is a crime that would have any bearing on the credibility of Wear’s potential testimony. In addition, the Court finds that evidence of Michael Wear’s indictment for these crimes is of very low probative value, if any, and not relevant to the issues to be decided at trial. The Court will also exclude evidence of Mr. Nam Hyun Lee’s conviction, including his guilty plea and any related documents. Mr. Lee’s situation is substantially different from the context of the instant litigation, in that Mr. Lee was prosecuted by the government for smuggling and importing drugs, rather than sued by a private party for retail sales under RICO and/or the Lanham Act. Thus, his prosecution, conviction, and criminal history have extremely low probative value, if any, and little relevance to the issues central to this case. The Court will also exclude this evidence based on a tendency to confuse the jury, who might think that the government’s success in prosecuting Mr. Lee lends credence to Tauler Smith’s actions as a non-governmental actor. The Court further excludes Tauler Smith’s Exhibit B, “selected criminal prosecutions over related products throughout the country” for the same reasons articulated above, related to Mr. Lee. The Court HEREBY GRANTS Motion in Limine No. 2 and excludes evidence regarding the criminal prosecutions of any persons, including Michael Wear and Nam Hyun Lee. C. Motion in Limine No. 3: Denials of Demurrers and Motions to Dismiss in Other Outlaw Cases (ECF No. 390) Plaintiffs seek to exclude Tauler Smith’s Exhibit H, which consists of three orders: (1) the overruling of a demurrer brought by one of the defendants in Outlaw Laboratory v. Lucky Liquor & Mini Mart, et al. (L.A. Sup. Ct. No. SC129302); (2) the overruling of a demurrer in an unspecified California jurisdiction, Case No. BC706471, brought by defendants Overland Mobil Mart and MV Petroleum Corp.; and (3) the denial of a motion to dismiss brought by a defendant in Outlaw Laboratory v. US1 Novelties LLC, et al., No. 18-cv-2065-AT in the Northern District of Georgia. See ECF No. 390 at 2. All three of these cases are decisions on the pleadings stage—i.e., they do not look to the underlying merits of the action, but simply assess whether Outlaw met its burden of pleading at the outset of litigation. As such, they have very little probative value for Tauler Smith’s proposed use: to show that courts ruled in Outlaw’s favor on the merits, thus making it reasonable for them to send the demand letters at issue. The Court finds that these cases have a high likelihood of confusing the jury, which outweighs their minimal probative value, as a jury is unlikely to understand the difference between a motion on the pleadings and a motion on the merits. In addition, any explanation of the difference would waste valuable trial time while producing little benefit for either side. To be clear, the Court is unconvinced that these three cases lend support for Tauler Smith’s contention in the first place. If Tauler Smith were offering cases predating the instant litigation in which a judge had ruled in their favor, even at the pleadings stage, that would be one thing. But each of the three cases offered in Exhibit H was decided after Tauler Smith and Outlaw filed the initial Complaint in this action. Therefore, any decision rendered in Tauler Smith and Outlaw’s favor in these three cases could not possibly have lent credence to Tauler Smith’s legal theory and supported the legal soundness of the letters to the Stores before they were sent. Even if such orders could be assumed to a post-hoc vindication of Tauler Smith’s approach—which, since they are not orders on the merits, they cannot be—the Court finds that the cases are excludable evidence due to their low probative value and tendency to confuse the jury and waste time at trial. Given the timing of the decisions, the cases certainly do not lend support to the theory that Tauler Smith’s demands were supported by their own legal victories at the time that the demand letters were sent out in the instant action. The Court therefore GRANTS Motion in Limine No. 3. D. Motion in Limine No. 4: Health Effects Attributed to Subject Pills (ECF No. 391) Plaintiffs seek to exclude evidence or arguments as to adverse health effects allegedly caused by the sexual enhancement pills at issue, including Tauler Smith’s proposed witness, Maxine Fleming. ECF No. 391 at 2. According to Tauler Smith’s witness list, Ms. Fleming will be called to testify that her husband had a stroke after consuming the subject pills. The Court will exclude Ms. Fleming’s testimony on several grounds. First, the testimony of a nonparty as to her husband’s stroke has little or no relevance to the question of Tauler Smith’s potential liability under RICO.

Free access — add to your briefcase to read the full text and ask questions with AI

Outlaw Laboratory, LP v. DG in PB, LLC, (S.D. Cal. 2022).

Outlaw Laboratory, LP v. DG in PB, LLC (Outlaw Laboratory, LP v. DG in PB, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

People v. Linton
302 P.3d 927 (California Supreme Court, 2013)